Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Australasian Journal of Dermatology (2019) , – doi: 10.1111/ajd.

13111

BRIEF REPORT

Atypical severe progressive perioral ulceration due to


herpes simplex virus on the background of undiagnosed
HIV/AIDS
Matthew David Howard1 | Flora Poon2 | Olivia Jean Milne2 | Anthony Kelmann3 |
Alvin H Chong4,5
1
Victorian Melanoma Service, Alfred Hospital, Melbourne, Departments of 2Dermatology, and 3Pathology,
Monash Health, Clayton, 4Skin & Cancer Foundation Inc., and 5Department of Medicine, St Vincent’s Hospital,
University of Melbourne, Melbourne, Victoria, Australia

CASE REPORT
ABSTRACT A 43-year-old Sri Lankan male refugee, presented with a
Perioral ulcerative plaques have a broad list of dif- 5-month history of enlarging ulcerative plaques affecting
ferential diagnoses. We describe an unusual presen- his right lateral commissure lip extending into his cheek.
tation of chronic progressive perioral ulceration due He also had an eroded area with a papulovesicular edge
to herpes simplex type (HSV)-1 on a background of affecting his left mastoid process (Fig. 1). There was no
undiagnosed human immunodeficiency virus infec- involvement of his internal oral mucosa. There was no
tion with acquired immunodeficiency syndrome. clinical lymphadenopathy. The patient had a background
Whilst chronic mucocutaneous HSV is an AIDS- history of perianal fissures and fistulas. Previous surgery
defining condition with both HSV-1 and HSV-2 included a sigmoidoscopy and perianal fissure and
implicated, typical reported cases describe vesicular abscess debridement 2 years prior and a seton insertion
eruptions rather than perioral ulcerative plaques. 5 months prior. There was no past personal or family
This case highlights that common infections may history of auto-inflammatory disorders. The last reported
present atypically in immunocompromised individu- travel overseas to Sri Lanka was 1 year prior. Further
als and may be a clue to underlying systemic illness. systems review revealed weight loss but no other consti-
tutional symptoms. Previous biopsies of the lip ulcer
Key words: herpes simplex virus, HIV, HSV, yielded granulation tissue only. Topical hydrozole and
human immunodeficiency virus, ulceration. mupirocin ointment was initiated by his local family doc-
tor but were of no benefit.
The differential diagnosis was broad for this case
and included both an infective and auto-inflammatory
processes.
INTRODUCTION Histopathology of repeat biopsies revealed a necrotic
epidermis with heavy neutrophil infiltrate and multinucle-
Perioral ulcerative plaques have many differential diag-
ated keratinocytes (Fig. 2). Specific immunohistochemistry
noses. In this case, we describe an unusual presentation of
was positive for the HSV-1 virus within epithelial cells.
chronic progressive perioral ulceration due to the herpes
Wound swabs for microscopy, culture, sensitivity and HSV
simplex (HSV) type 1 virus.
polymerase chain reaction (PCR) were taken which
showed mixed skin flora, no polymorphs and HSV-1-speci-
fic positivity, respectively. Herpes simplex type 2 PCR was
negative. Leishmania PCR was negative on tissue culture
Correspondence: Dr Matthew David Howard, Victorian Mela- of the punch biopsies in addition to serology. Further full
noma Service, Alfred Hospital, 55 Commercial Rd, Melbourne, Vic. blood examination revealed a lymphocytopenia
3004, Australia. Email: Matthew.david.howard@gmail.com (0.33 9 109/L, normal 1.0–4.0 9 109/L) with subsequent
Matthew David Howard, MBBS (Hons), BPharm (Hons). Flora HIV testing performed in view of the atypical HSV ulcera-
Poon, MBBS, MHSc. Olivia Jean Milne, MBBS, BVSc, FACD.
tion found to be positive with a viral load of 4 394 463
Anthony Kelmann, MBBS. Alvin H Chong, MBBS, M.Med, FACD.
Funding sources: None.
copies/mL. There was a significant decreased CD3/CD4
Conflict of interest: None. ratio of 2% (normal: 31–59%) and absolute CD4 count of 6
Submitted 12 April 2019; accepted 5 June 2019. (389–1569).

© 2019 The Australasian College of Dermatologists


2 MD Howard et al.

Dual clinicopathologic diagnoses of severe HSV-1 ulcera- tracing, and psychosocial patient–family counselling is
tion in addition to a new diagnosis of HIV were made. underway.
Together with infectious diseases specialists, the patient
was commenced on antiretroviral therapy [emtricitabine–
DISCUSSION
tenofovir alafenamide combination tablet (Descovyâ) 200/
25 mg daily and dolutegravir 50 mg daily] along with This case highlights that atypical ulcerative HSV infection
famciclovir 500 mg twice daily for treatment of HSV. Addi- can present on the background of undiagnosed immunosup-
tional antimicrobial prophylaxes commenced by the infec- pression, where it is a recognised AIDS-defining illness,1
tious disease team were: trimethoprim/sulfamethoxazole although in our case, our patient met the criteria for AIDS
160/800 mg three times per week for Pneumocystis jirovecii on low CD4 count. With directed investigations towards
prophylaxis, benzylpenicillin 1.8 g intramuscular single potential predisposing factors towards HSV, prompt multi-
dose given the patient had prior positive treponemal test- disciplinary treatment is crucial for patients.
ing, thiamine 100 mg daily and moxifloxacin 400 mg daily Patients with immunodeficiency are at higher risk of
for prophylaxis of hospital-acquired pneumonia and treat- developing a severe HSV infection with recurrent infection
ment of potential mycobacterium tuberculosis given severe often more extensive, protracted, symptomatic and aggres-
acquire immuno-deficiency and fevers that later developed sive in nature.2,3 Unlike its well-recognised vesicular erup-
during the inpatient stay. Serial blood cultures, bronchial tion in the immunocompetent population,2 HSV infection
washings, sputum cultures and Quantiferon gold testing presents atypically in the immunocompromised.3 Knife-like
were negative for M. tuberculosis infection and other ulceration (a distinctive presentation of linear erosive her-
pathogens. After 2 weeks of antiviral therapy, both ulcers pes simplex virus infection in intertriginous areas),4 pri-
healed with significant post-inflammatory hypopigmenta- mary herpetic gingivostomatitis,3 conjunctivitis,2 severe
tion (Fig. 3) and the HIV viral load responded to antiretro- herpetic whitlow,1 persistent irregular ulcerative plaques,1–3
viral therapy (less than 40 copies/mL). After this period, pseudovesicular erythematous papules coalescing into
famciclovir was replaced with valganciclovir for cytomega- plaques,1 Grossman geometric glossitis (tender dorsal ton-
lovirus prophylaxis 900 mg twice daily. gue fissures in a longitudinal, cross-hatched or branched
The patient is currently receiving close monitoring pattern),5 hypertrophic, condylomatous or tumour-like
whilst on retroviral treatment and ongoing contact exophytic masses3,6 and large chronic eroded lesions

Figure 1 Large area of ulceration affecting the right lateral commissure lip and smaller ulcerated plaque affecting the left mastoid pro-
cess prior to referral.

Figure 2 Left image arrow pointing to HSV inclusion in necrotic keratinocyte. Other necrotic keratinocytes, macrophages and part of
some foreign material are also present (HE 9400). Right image: Arrow points to positive immunohistochemical assay for HSV-1 (9400).

© 2019 The Australasian College of Dermatologists


Atypical perioral ulceration from HSV 3

Figure 3 Healed ulcerative plaques with hypo- and hyperpigmentation on the right lateral commissure lip and left mastoid process after
2 weeks of antiviral and antiretroviral therapy.

mimicking pemphigus vulgaris and bullous pemphigoid REFERENCES


have all been reported.7 Fatal systemic infections due to
disseminated infection without orofacial or genital lesions 1. Langtry J, Ostlere L, Hawkins D et al. The difficulty in diagno-
sis of cutaneous herpes simplex virus infection in patients
are possible in the immunocompromised population,3 with
with AIDS. Clin. Exp. Dermatol. 1994; 19: 224–6.
recurrent severe HSV-1 infections a major cause of mor- 2. Arduino P, Porter S. Herpes Simplex Virus Type 1 infection:
bidity and mortality in immunocompromised patients prior overview on relevant clinico-pathological features. J. Oral
to the availability of current antiviral therapies.2 Cellular Pathol. Med. 2008; 37: 107–21.
immunodeficiencies that are associated with atypical HSV 3. Fatahzadeh M, Schwartz R. Human herpes simplex virus infec-
manifestations include the following: primary congenital tions: epidemiology, pathogenesis, symptomatology, diagnosis,
and management. J. Am. Acad. Dermatol. 2007; 57: 737–63.
cellular immunodeficiencies,8 acute and chronic leukae-
4. Lieb J, Brisman S, Herman S et al. Linear erosive herpes sim-
mias,6 Good syndrome,9 iatrogenic immunosuppression of plex virus infection in immunocompromised patients: the
autoimmune conditions,7 organ transplant recipients6 and “knife-cut sign”. Clin. Infect. Dis. 2008; 47: 1440–1.
also through chemotherapy treatment of malignancy6 as 5. Grossman M, Stevens A, Cohen P. Brief report: herpetic geo-
well as AIDS.1 metric glossitis. N. Engl. J. Med. 1993; 329: 1859–60.
The punched out peripheral monomorphic papulovesicles 6. Ogawa Y, Higuchi T, Koyamada R et al. Hypertrophic herpes
simplex virus type 1 Infection in a patient with acute myeloid
and location on the lateral lip commissure provided clinical
leukemia. J. Hematol. 2017; 6: 68–71.
clues towards a diagnosis of an atypical HSV infection. Nega- 7. Lecluse A, Bruijnzeel-Koomen C. Herpes simplex virus infec-
tive tissue biopsies/immunofluorescence for diagnosis of tion mimicking bullous disease in an immunocompromised
HSV is possible depending on whether active infection is patient. Case Rep. Dermatol. 2010; 2: 99–102.
present in the tissue sampled.10 Despite reports of increased 8. Raje N, Dinakar C. Overview of immunodeficiency disorders.
resistance, our patient responded quickly to anti-HSV treat- Immunol. Allergy Clin. North Am. 2015; 35: 599–623.
ment with famciclovir. This may have been assisted by 9. Kelleher P, Misbah SA. What is Good’s syndrome? Immunolog-
ical abnormalities in patients with thymoma. J. Clin. Pathol.
improved adaptive immunity due to commencement of
2003; 56: 12–6.
antiretroviral combination therapy, which resulted in quick 10. LeGoff J, Pe re
 H, Be
lec L. Diagnosis of genital herpes simplex
suppression of the HIV viral load. virus infection in the clinical laboratory. Virol. J. 2014; 11: 83.

© 2019 The Australasian College of Dermatologists

You might also like